Mark Titus

Title: The Innovations of Mark Titus

Introduction

Mark Titus is an accomplished inventor based in Chapel Hill, NC (US). He is known for his significant contributions to the field of biochemistry, particularly in the development of novel enzymes. His work has implications for understanding and treating prostate cancer.

Latest Patents

Mark Titus holds a patent for a novel steroid 5α-reductase enzyme termed SRD5AIII. This enzyme has an estimated molecular weight of 37 kDa and is capable of converting testosterone to dihydrotestosterone at a pH of about 7.0. The patent also outlines a method for identifying inhibitors of SRD5AIII by measuring the enzyme's activity in the presence of test compounds. A reduced activity compared to a control indicates that the test compound is an inhibitor. Additionally, the patent provides a method for detecting androgen-stimulated prostate cancer or recurrent prostate cancer by analyzing the expression levels of the SRD5AIII gene or protein in prostate biopsies.

Career Highlights

Mark Titus is affiliated with Health Research, Inc., where he continues to advance his research in enzymology and cancer detection. His innovative work has led to a deeper understanding of the biochemical pathways involved in prostate cancer.

Collaborations

Mark has collaborated with notable colleagues such as James L. Mohler and Olga Kozyreva, contributing to the advancement of research in his field.

Conclusion

Mark Titus's contributions to the field of biochemistry, particularly through his patent on the SRD5AIII enzyme, highlight his role as an influential inventor. His work not only enhances our understanding of hormone-related cancers but also opens avenues for potential therapeutic interventions.